久久久久亚洲精品无码网址-自拍日韩亚洲一区在线-日本人妻伦在线中文字幕-露脸内射熟女--69xx

北京百奧創(chuàng)新科技有限公司
全國咨詢熱線:15522676233
人類神經(jīng)元
  • 品牌:Accegen
  • 產(chǎn)地:美國
  • 貨號:ABC-TC3722
  • 發(fā)布日期: 2022-09-21
  • 更新日期: 2024-08-12
產(chǎn)品詳請
產(chǎn)地 美國
保存條件 Dry Ice
品牌 Accegen
貨號 ABC-TC3722
用途 詳詢
組織來源 詳詢
細胞形態(tài) 詳詢
是否是腫瘤細胞
CAS編號
保質(zhì)期 詳詢
器官來源 詳詢
免疫類型 詳詢
品系 詳詢
生長狀態(tài) 詳詢
物種來源 詳詢
包裝規(guī)格 1 vial
純度 詳詢%
是否進口
product name:Human Neurons;
cat no:ABC-TC3722;
Size/Quantity:1 vial;
Biosafety Level:1;
Shipping Info:Dry Ice;
Storage:Liquid Nitrogen;
Description:Human neurons (HN) mainly reside in central nervous system, but also distribute in multiple other parts of the brain such as peripheral ganglia, retina and cochlea. Neurons are highly specialized for the processing and transmission of cellular signals. Transmitting information is the exceptional character that distinguishes neurons from other cells.

Neuron stops reproduction shortly after birth and is unable to replace the old one. Consequently, some diseases like neurodegenerative disease (e.g. Parkinson’s disease, Alzheimer’s disease and Huntington’s disease) that damage nerve cells are hard to cure. Another obstacle of research on human nervous system research is the lack of neuronal cells due to the difficulty of isolating neurons from living patients. Primary neurons can be easily cultured and differentiated into neurons. Thus, primary neurons culture has become one of the most elementary methodologies for modern neurobiology.;
Quality Control:All cells test negative for mycoplasma, bacteria, yeast, and fungi;
Application:For research use only.
北京百奧創(chuàng)新代理Accegen在中國的業(yè)務(wù)。
北京百奧創(chuàng)新科技有限公司:
一、輻射五大服務(wù)方向:
國內(nèi)試劑耗材經(jīng)銷代理;
國外試劑訂購(直訂或境外代理);
基因組測序(二代、二代+三代);
基因分型(SNP檢測):低/中/高通量項目;
生物樣本運輸;

二、多家授權(quán)代理品牌,涉及30多種,經(jīng)營代理500多個品牌:
Accegen、Intact Genomic、Sigma、Epigentek、ThermoFisher、DNA Genotek、USA Scientific......
所有生物試劑耗材都可以進口,特別是冷門品牌,價格優(yōu),貨期短,可加急。大部分客戶我們提供貨到付款服務(wù),百奧創(chuàng)新自成立依靠過硬的服務(wù)和良好的信譽與各大企事業(yè)單位、科研單位建立長期合作。
專業(yè)訂購國內(nèi)外試劑耗材,常備現(xiàn)貨,一手貨源,歡迎合作
? ? ? ? ? ? ? ? ? ? ? ?